Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregabalin for Pain Reduction in Critical Limb Ischemia - A Double Blind, Randomized Controlled Study

NCT00403780 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT00403780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregabalin for Pain Reduction in Critical Limb Ischemia - A Double Blind, Randomized Controlled Study
Lead sponsor
Karolinska Institutet
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2006
Completion date
July 31, 2015
Enrollment
18 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive disease, critical limb ischemia, ischemia, pain